News
-
-
-
PRESS RELEASE
Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG
Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG. Shareholders approve all agenda items. New member elected to the Supervisory Board. CEO highlights company's strategy and unique selling points -
PRESS RELEASE
ParTec and BF exaQC Take Note of Largely Favorable but Dismissive First-Instance Ruling. A Pyrrhic Victory for NVIDIA?!
ParTec and BF exaQC take note of largely favorable but dismissive ruling by the European Unified Patent Court confirming NVIDIA's use of patented architecture. Appeal planned -
PRESS RELEASE
EQS-Adhoc: Knaus Tabbert AG publishes selected preliminary financial figures for the 2025 financial year
Knaus Tabbert AG releases preliminary financial figures for 2025, reporting EUR 1.002 billion revenue and 2.7% adjusted EBITDA margin. Final audited results to be published on 31 March 2026 -
-
PRESS RELEASE
Dans le cadre de son projet de transfert sur Euronext Growth, MACOMPTA.FR organise un webinaire le mardi 17 mars à 18h
MACOMPTA.FR, éditeur de solutions logicielles, organise une visioconférence pour investisseurs sur son transfert sur Euronext Growth. Performances et objectifs de croissance de la société -
-
-